A detailed history of Credit Agricole S A transactions in Biogen Inc. stock. As of the latest transaction made, Credit Agricole S A holds 33,812 shares of BIIB stock, worth $6.28 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
33,812
Previous 11,325 198.56%
Holding current value
$6.28 Million
Previous $2.44 Million 220.97%
% of portfolio
0.04%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$190.52 - $236.72 $4.28 Million - $5.32 Million
22,487 Added 198.56%
33,812 $7.84 Million
Q1 2024

May 14, 2024

BUY
$212.02 - $267.71 $1.23 Million - $1.55 Million
5,790 Added 104.61%
11,325 $2.44 Million
Q4 2023

Feb 13, 2024

BUY
$222.59 - $267.94 $633,268 - $762,289
2,845 Added 105.76%
5,535 $1.43 Million
Q3 2023

Nov 14, 2023

BUY
$253.3 - $285.89 $15,198 - $17,153
60 Added 2.28%
2,690 $691,000
Q2 2023

Jul 31, 2023

BUY
$275.25 - $318.06 $657,847 - $760,163
2,390 Added 995.83%
2,630 $749,000
Q1 2023

May 12, 2023

SELL
$256.56 - $292.34 $434,869 - $495,516
-1,695 Reduced 87.6%
240 $66,000
Q4 2022

Feb 13, 2023

BUY
$252.44 - $306.72 $427,885 - $519,890
1,695 Added 706.25%
1,935 $535,000
Q3 2022

Nov 10, 2022

SELL
$194.69 - $268.46 $93,840 - $129,397
-482 Reduced 66.76%
240 $64,000
Q2 2022

Aug 08, 2022

SELL
$187.54 - $223.02 $111,586 - $132,696
-595 Reduced 45.18%
722 $147,000
Q1 2022

May 16, 2022

BUY
$193.77 - $244.14 $137,576 - $173,339
710 Added 116.97%
1,317 $278,000
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $57,547 - $73,956
257 Added 73.43%
607 $146,000
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $38,486 - $50,190
136 Added 63.55%
350 $99,000
Q2 2021

Aug 10, 2021

SELL
$259.0 - $414.71 $74,074 - $118,607
-286 Reduced 57.2%
214 $74,000
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $72,885 - $85,389
300 Added 150.0%
500 $140,000
Q3 2020

Nov 13, 2020

BUY
$264.77 - $305.71 $12,973 - $14,979
49 Added 32.45%
200 $57,000
Q2 2020

Aug 13, 2020

SELL
$258.66 - $342.55 $810,123 - $1.07 Million
-3,132 Reduced 95.4%
151 $40,000
Q1 2020

May 14, 2020

SELL
$268.85 - $341.04 $1.42 Million - $1.8 Million
-5,272 Reduced 61.62%
3,283 $1.04 Million
Q4 2019

Feb 12, 2020

SELL
$220.06 - $304.07 $2.32 Million - $3.21 Million
-10,543 Reduced 55.2%
8,555 $2.54 Million
Q3 2019

Nov 08, 2019

BUY
$217.44 - $243.88 $208,307 - $233,637
958 Added 5.28%
19,098 $4.45 Million
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $122,144 - $134,638
557 Added 3.17%
18,140 $4.24 Million
Q1 2019

May 14, 2019

BUY
$216.71 - $338.96 $835,417 - $1.31 Million
3,855 Added 28.08%
17,583 $4.16 Million
Q4 2018

Feb 13, 2019

BUY
$278.5 - $352.75 $181,025 - $229,287
650 Added 4.97%
13,728 $4.13 Million
Q3 2018

Nov 13, 2018

SELL
$293.51 - $383.83 $4.9 Million - $6.41 Million
-16,700 Reduced 56.08%
13,078 $4.62 Million
Q2 2018

Aug 10, 2018

BUY
$257.52 - $306.91 $1.33 Million - $1.59 Million
5,180 Added 21.06%
29,778 $8.64 Million
Q1 2018

May 14, 2018

BUY
$260.13 - $367.91 $715,357 - $1.01 Million
2,750 Added 12.59%
24,598 $6.74 Million
Q4 2017

Feb 13, 2018

SELL
$307.64 - $344.58 $47.4 Million - $53 Million
-153,951 Reduced 87.57%
21,848 $6.96 Million
Q3 2017

Nov 14, 2017

SELL
$281.15 - $329.69 $14.7 Million - $17.3 Million
-52,323 Reduced 22.94%
175,799 $55 Million
Q2 2017

Aug 14, 2017

BUY
N/A
228,122
228,122 $61.9 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $26.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.